These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2951064)
1. Effect of sulphonylurea administration on insulin secretion and amino acid metabolism in non-insulin-dependent diabetic patients. Paterson KR; Gyi KM; McBride D; Cohen HN; Shenkin A; Manderson WG; MacCuish AC Diabet Med; 1985 Jan; 2(1):38-40. PubMed ID: 2951064 [TBL] [Abstract][Full Text] [Related]
2. Diabetes and branched-chain amino acids: What is the link? Bloomgarden Z J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529 [TBL] [Abstract][Full Text] [Related]
3. The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state. Matthews DR; Boland O Metabolism; 1997 Dec; 46(12 Suppl 1):5-9. PubMed ID: 9439551 [TBL] [Abstract][Full Text] [Related]
4. Effect of middle-term gliclazide treatment on insulin secretion in non-insulin dependent diabetics. Brogard JM; Pinget M; Dorner M Curr Med Res Opin; 1984; 9(1):56-63. PubMed ID: 6373160 [TBL] [Abstract][Full Text] [Related]
5. The effect of sulphonylurea therapy on skeletal muscle glycogen synthase activity and insulin secretion in newly presenting type 2 (non-insulin-dependent) diabetic patients. Johnson AB; Argyraki M; Thow JC; Jones IR; Broughton D; Miller M; Taylor R Diabet Med; 1991 Apr; 8(3):243-53. PubMed ID: 1828740 [TBL] [Abstract][Full Text] [Related]
6. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control. Vestergaard H; Lund S; Bjørbaek C; Pedersen O Diabetologia; 1995 Oct; 38(10):1230-8. PubMed ID: 8690177 [TBL] [Abstract][Full Text] [Related]
7. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin. Portha B; Serradas P Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320 [TBL] [Abstract][Full Text] [Related]
8. Effect of 6 months' gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial CSII-induced normoglycemia. Della Casa L; del Rio G; Glaser B; Cerasi E Diabetes Res Clin Pract; 1991; 14 Suppl 2():S69-78. PubMed ID: 1794269 [TBL] [Abstract][Full Text] [Related]
9. The physiological action of gliclazide: beta-cell function and insulin resistance. Matthews DR; Hosker JP; Stratton I Diabetes Res Clin Pract; 1991; 14 Suppl 2():S53-9. PubMed ID: 1794266 [TBL] [Abstract][Full Text] [Related]
10. [Personal experience with combined treatment of gliclazide and insulin in patients with non-insulin-dependent diabetes (type 2) and late secondary failure of sulphonylureas]. Zapecka-Dubno B; Wiśniewska K; Szczepanik Z; Kasperska-Czyzykowa T Pol Arch Med Wewn; 1993 Jun; 89(6):499-506. PubMed ID: 8415212 [TBL] [Abstract][Full Text] [Related]
11. A comparison of treatment with metformin and gliclazide in patients with non-insulin-dependent diabetes. McAlpine LG; McAlpine CH; Waclawski ER; Storer AM; Kay JW; Frier BM Eur J Clin Pharmacol; 1988; 34(2):129-32. PubMed ID: 3289948 [TBL] [Abstract][Full Text] [Related]
12. Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non-insulin-dependent diabetic subjects. Ward G; Harrison LC; Proietto J; Aitken P; Nankervis A Diabetes; 1985 Mar; 34(3):241-5. PubMed ID: 3882491 [TBL] [Abstract][Full Text] [Related]
13. Is sulphonylurea therapy effective long term? A 3-year study with gliclazide. Zurro Hernandez J; Lavielle R Curr Med Res Opin; 1986; 10(5):351-8. PubMed ID: 3816294 [TBL] [Abstract][Full Text] [Related]
14. Effect of 6-month gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial continuous subcutaneous insulin infusion-induced normoglycemia. Della Casa L; del Rio G; Glaser B; Cerasi E Am J Med; 1991 Jun; 90(6A):37S-45S. PubMed ID: 1872303 [TBL] [Abstract][Full Text] [Related]
15. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin. Serradas P; Bailbé D; Portha B Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491 [TBL] [Abstract][Full Text] [Related]
16. Effect of prolonged gliclazide therapy in non-insulin dependent diabetic subjects. Donatelli M; Sinagra D; Russo V; Bucalo ML; Giardina E; Cerasola GA; Bompiani G Pharmatherapeutica; 1985; 4(2):69-75. PubMed ID: 3903780 [TBL] [Abstract][Full Text] [Related]
17. The effects of long term gliclazide administration on insulin secretion and insulin sensitivity. Ma A; Kamp M; Bird D; Howlett V; Cameron DP Aust N Z J Med; 1989 Feb; 19(1):44-9. PubMed ID: 2669710 [TBL] [Abstract][Full Text] [Related]
18. [Metabolic effects of gliclazide in diabetes type II patients. Study with indirect calorimetry]. Golay A; Broquet C; Chabot V; Studer S; Felber JP Schweiz Med Wochenschr; 1984 Feb; 114(8):261-4. PubMed ID: 6369531 [TBL] [Abstract][Full Text] [Related]
19. Effect of gliclazide on non-insulin dependent diabetes mellitus. Wajchenberg BJ; Santomaruo AT; Cherem JJ; Malerbi DA; Giurno Filho A; Lerario AC; Giannella Neto D Adv Exp Med Biol; 1988; 246():313-9. PubMed ID: 3074661 [No Abstract] [Full Text] [Related]
20. Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus. Palmer KJ; Brogden RN Drugs; 1993 Jul; 46(1):92-125. PubMed ID: 7691511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]